Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cash Earnings per Share (CEPS)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   CEPS(Rs) 22.3222.5620.01-33.8410.16

What is the latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) ?

The latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) is 22.32 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202522.32
Mar202422.56
Mar202320.01
Mar2022-33.84
Mar201310.16

How is Cash Earnings per Share (CEPS) of NATH BIOGENES (INDIA) Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 22.32
-1.06
Mar2024 22.56
12.74
Mar2023 20.01
Positive
Mar2022 -33.84
Negative
Mar2013 10.16 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Cash Earnings per Share (CEPS) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹321.1 Cr -2.3% -2.1% -11.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,294.7 Cr -2.5% 3.3% -28.6% Stock Analytics
KAVERI SEED COMPANY ₹5,011.2 Cr -5.5% -8.1% 7.7% Stock Analytics
VENKYS (INDIA) ₹1,881.8 Cr -13.2% -10.3% -25.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,264.8 Cr -1.6% -3.3% -24.5% Stock Analytics
INDO US BIOTECH ₹263.5 Cr -3.5% -0.4% -51.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.3%

-2.1%

-11.7%

SENSEX

-0.1%

2.6%

6.5%


You may also like the below Video Courses